| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 8.25e-08 | 46 | 48 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.68e-06 | 188 | 48 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 5.63e-05 | 5 | 48 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 3.07e-04 | 11 | 48 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 3.68e-04 | 12 | 48 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | collagen binding | 9.75e-04 | 81 | 48 | 3 | GO:0005518 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 5.08e-06 | 2 | 47 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 5.08e-06 | 2 | 47 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 1.52e-05 | 3 | 47 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.52e-05 | 3 | 47 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 1.52e-05 | 3 | 47 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 1.87e-05 | 144 | 47 | 5 | GO:0006354 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 3.04e-05 | 4 | 47 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 6.31e-05 | 34 | 47 | 3 | GO:0006353 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 7.58e-05 | 6 | 47 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.06e-04 | 1053 | 47 | 10 | GO:0000122 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.99e-04 | 127 | 47 | 4 | GO:0006368 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.04e-04 | 377 | 47 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.07e-04 | 378 | 47 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.10e-04 | 379 | 47 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 3.82e-04 | 62 | 47 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 5.98e-04 | 16 | 47 | 2 | GO:0006369 | |
| GeneOntologyCellularComponent | collagen trimer | 4.38e-08 | 88 | 47 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL18A1 COL15A1 COL16A1 LOX ANXA11 CSPG4 COL25A1 SSPOP | 2.34e-06 | 530 | 47 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL18A1 COL15A1 COL16A1 LOX ANXA11 CSPG4 COL25A1 SSPOP | 1.31e-05 | 656 | 47 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL18A1 COL15A1 COL16A1 LOX ANXA11 CSPG4 COL25A1 SSPOP | 1.34e-05 | 658 | 47 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.37e-04 | 8 | 47 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | RSC-type complex | 5.10e-04 | 15 | 47 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 8.70e-04 | 332 | 47 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.31e-03 | 96 | 47 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.76e-03 | 230 | 47 | 4 | GO:0019898 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.07e-03 | 30 | 47 | 2 | GO:0016514 | |
| Domain | Collagen | 2.82e-06 | 85 | 49 | 5 | PF01391 | |
| Domain | Collagen | 2.82e-06 | 85 | 49 | 5 | IPR008160 | |
| Domain | Endostatin | 6.74e-06 | 2 | 49 | 2 | PF06482 | |
| Domain | Collagenase_NC10/endostatin | 6.74e-06 | 2 | 49 | 2 | IPR010515 | |
| Domain | Laminin_G | 1.60e-05 | 58 | 49 | 4 | IPR001791 | |
| Domain | TSPN | 2.90e-05 | 23 | 49 | 3 | SM00210 | |
| Domain | - | 4.23e-05 | 26 | 49 | 3 | 1.25.40.90 | |
| Domain | ENTH_VHS | 5.91e-05 | 29 | 49 | 3 | IPR008942 | |
| Domain | RNA_pol_II-bd | 1.40e-04 | 7 | 49 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.40e-04 | 7 | 49 | 2 | PF04818 | |
| Domain | RPR | 1.87e-04 | 8 | 49 | 2 | SM00582 | |
| Domain | CID_dom | 1.87e-04 | 8 | 49 | 2 | IPR006569 | |
| Domain | CID | 1.87e-04 | 8 | 49 | 2 | PS51391 | |
| Domain | LamG | 2.08e-04 | 44 | 49 | 3 | SM00282 | |
| Domain | Homeodomain-like | 1.73e-03 | 332 | 49 | 5 | IPR009057 | |
| Domain | ConA-like_dom | 2.58e-03 | 219 | 49 | 4 | IPR013320 | |
| Domain | CTDL_fold | 2.78e-03 | 107 | 49 | 3 | IPR016187 | |
| Domain | KH_1 | 4.46e-03 | 38 | 49 | 2 | PF00013 | |
| Domain | MYB_LIKE | 4.46e-03 | 38 | 49 | 2 | PS50090 | |
| Domain | - | 4.70e-03 | 39 | 49 | 2 | 3.30.1370.10 | |
| Domain | KH | 4.94e-03 | 40 | 49 | 2 | SM00322 | |
| Domain | KH_dom | 4.94e-03 | 40 | 49 | 2 | IPR004087 | |
| Domain | KH_TYPE_1 | 5.43e-03 | 42 | 49 | 2 | PS50084 | |
| Domain | KH_dom_type_1 | 5.95e-03 | 44 | 49 | 2 | IPR004088 | |
| Domain | - | 6.40e-03 | 283 | 49 | 4 | 1.10.10.60 | |
| Domain | Znf_FYVE_PHD | 6.75e-03 | 147 | 49 | 3 | IPR011011 | |
| Domain | SANT | 7.62e-03 | 50 | 49 | 2 | SM00717 | |
| Domain | SANT/Myb | 8.22e-03 | 52 | 49 | 2 | IPR001005 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.63e-08 | 76 | 32 | 6 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.07e-08 | 41 | 32 | 5 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.43e-08 | 44 | 32 | 5 | M27812 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.54e-08 | 90 | 32 | 6 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.36e-07 | 61 | 32 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.01e-07 | 64 | 32 | 5 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.80e-07 | 67 | 32 | 5 | M26999 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.68e-06 | 50 | 32 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.92e-06 | 53 | 32 | 4 | MM14566 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.04e-05 | 61 | 32 | 4 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.46e-05 | 140 | 32 | 5 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.15e-05 | 258 | 32 | 6 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.02e-05 | 300 | 32 | 6 | M610 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 5.12e-05 | 301 | 32 | 6 | MM15983 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.22e-04 | 114 | 32 | 4 | MM14571 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.51e-04 | 46 | 32 | 3 | M198 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.41e-04 | 66 | 32 | 3 | M18 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.17e-04 | 74 | 32 | 3 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.67e-04 | 76 | 32 | 3 | MM14867 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.47e-04 | 18 | 32 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.47e-04 | 18 | 32 | 2 | MM14882 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.25e-04 | 85 | 32 | 3 | M16441 | |
| Pathway | WP_FAMILIAL_PARTIAL_LIPODYSTROPHY | 2.09e-03 | 30 | 32 | 2 | M42537 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.09e-03 | 30 | 32 | 2 | M27216 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.68e-03 | 34 | 32 | 2 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.16e-03 | 37 | 32 | 2 | M27797 | |
| Pubmed | 9.11e-11 | 167 | 49 | 8 | 22159717 | ||
| Pubmed | 7.86e-08 | 153 | 49 | 6 | 25037231 | ||
| Pubmed | 1.74e-07 | 175 | 49 | 6 | 28071719 | ||
| Pubmed | 2.76e-07 | 39 | 49 | 4 | 33580754 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.36e-06 | 135 | 49 | 5 | 28675934 | |
| Pubmed | Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII. | 1.94e-06 | 2 | 49 | 2 | 14614990 | |
| Pubmed | Variations in COL15A1 and COL18A1 influence age of onset of primary open angle glaucoma. | 1.94e-06 | 2 | 49 | 2 | 23621901 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25188209 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31104839 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11937714 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8188673 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24218547 | ||
| Pubmed | Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. | 1.94e-06 | 2 | 49 | 2 | 9501087 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8183894 | ||
| Pubmed | 2.00e-06 | 146 | 49 | 5 | 27068509 | ||
| Pubmed | 2.08e-06 | 64 | 49 | 4 | 22261194 | ||
| Pubmed | 3.25e-06 | 453 | 49 | 7 | 29656893 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.86e-06 | 167 | 49 | 5 | 20362541 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 8240330 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25593510 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18550522 | ||
| Pubmed | Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development. | 5.83e-06 | 3 | 49 | 2 | 15614762 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.50e-06 | 954 | 49 | 9 | 36373674 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8188291 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 11827796 | ||
| Pubmed | Mex3a Marks a Slowly Dividing Subpopulation of Lgr5+ Intestinal Stem Cells. | 1.16e-05 | 4 | 49 | 2 | 28285904 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.17e-05 | 774 | 49 | 8 | 15302935 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 20029986 | ||
| Pubmed | Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes. | 2.91e-05 | 6 | 49 | 2 | 19650111 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 16192629 | ||
| Pubmed | 3.36e-05 | 129 | 49 | 4 | 23022380 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 17324935 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 4.07e-05 | 922 | 49 | 8 | 27609421 | |
| Pubmed | COL4A1 PWWP2A COL18A1 ARHGAP23 OTUD5 LOX TMEM121B FUBP1 DIDO1 | 4.39e-05 | 1215 | 49 | 9 | 15146197 | |
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 5.42e-05 | 8 | 49 | 2 | 20130577 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 28940253 | ||
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 5.42e-05 | 8 | 49 | 2 | 9382709 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 36335117 | ||
| Pubmed | 5.53e-05 | 963 | 49 | 8 | 28671696 | ||
| Pubmed | Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro. | 6.96e-05 | 9 | 49 | 2 | 23320101 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 30355451 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 14531791 | ||
| Pubmed | 7.23e-05 | 157 | 49 | 4 | 30186101 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 9.37e-05 | 62 | 49 | 3 | 28344315 | |
| Pubmed | 1.11e-04 | 1371 | 49 | 9 | 36244648 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.18e-04 | 341 | 49 | 5 | 32971831 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.30e-04 | 807 | 49 | 7 | 22681889 | |
| Pubmed | 1.51e-04 | 1429 | 49 | 9 | 35140242 | ||
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 1.75e-04 | 14 | 49 | 2 | 8895581 | |
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 19542224 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 1.75e-04 | 14 | 49 | 2 | 36289231 | |
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 1.75e-04 | 14 | 49 | 2 | 20858856 | |
| Pubmed | Pericyte ALK5/TIMP3 Axis Contributes to Endothelial Morphogenesis in the Developing Brain. | 1.75e-04 | 14 | 49 | 2 | 29456135 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.93e-04 | 79 | 49 | 3 | 18757743 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.94e-04 | 203 | 49 | 4 | 22083510 | |
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 23785148 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 15985610 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 17640523 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 10087208 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 38942786 | ||
| Pubmed | 2.14e-04 | 1497 | 49 | 9 | 31527615 | ||
| Pubmed | 2.21e-04 | 210 | 49 | 4 | 16537572 | ||
| Pubmed | 2.30e-04 | 16 | 49 | 2 | 16880404 | ||
| Pubmed | 2.36e-04 | 396 | 49 | 5 | 26687479 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 2.61e-04 | 17 | 49 | 2 | 12368262 | |
| Pubmed | 2.61e-04 | 17 | 49 | 2 | 11078522 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.64e-04 | 220 | 49 | 4 | 35785414 | |
| Pubmed | 2.64e-04 | 220 | 49 | 4 | 24550385 | ||
| Pubmed | Developmental diversification of cortical inhibitory interneurons. | 2.93e-04 | 91 | 49 | 3 | 29513653 | |
| Pubmed | Genome-wide association of mood-incongruent psychotic bipolar disorder. | 2.93e-04 | 18 | 49 | 2 | 23092984 | |
| Pubmed | 3.01e-04 | 653 | 49 | 6 | 22586326 | ||
| Pubmed | Muscle composition is regulated by a Lox-TGFβ feedback loop. | 3.27e-04 | 19 | 49 | 2 | 25715398 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 3.27e-04 | 19 | 49 | 2 | 12110891 | |
| Pubmed | 3.27e-04 | 19 | 49 | 2 | 18809673 | ||
| Pubmed | 3.27e-04 | 19 | 49 | 2 | 29665133 | ||
| Pubmed | 3.27e-04 | 19 | 49 | 2 | 25066234 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.53e-04 | 97 | 49 | 3 | 27559042 | |
| Pubmed | 3.64e-04 | 20 | 49 | 2 | 9128241 | ||
| Pubmed | 4.01e-04 | 21 | 49 | 2 | 22479202 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.16e-04 | 248 | 49 | 4 | 24006456 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.17e-04 | 1294 | 49 | 8 | 30804502 | |
| Pubmed | 4.41e-04 | 22 | 49 | 2 | 35089129 | ||
| Pubmed | 4.41e-04 | 22 | 49 | 2 | 37532091 | ||
| Pubmed | Netrin 1 directs vascular patterning and maturity in the developing kidney. | 4.83e-04 | 23 | 49 | 2 | 37818607 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 4.83e-04 | 23 | 49 | 2 | 8804307 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 4.83e-04 | 23 | 49 | 2 | 30962207 | |
| Pubmed | 5.11e-04 | 469 | 49 | 5 | 27634302 | ||
| Pubmed | 5.18e-04 | 1014 | 49 | 7 | 32416067 | ||
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 12215535 | ||
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 5.26e-04 | 24 | 49 | 2 | 10078207 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.41e-04 | 475 | 49 | 5 | 31040226 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.49e-04 | 1024 | 49 | 7 | 24711643 | |
| Pubmed | 5.55e-04 | 733 | 49 | 6 | 34672954 | ||
| Pubmed | 5.56e-04 | 268 | 49 | 4 | 33640491 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.80e-04 | 271 | 49 | 4 | 32433965 | |
| Pubmed | 6.18e-04 | 26 | 49 | 2 | 38281222 | ||
| Pubmed | 6.18e-04 | 26 | 49 | 2 | 10778858 | ||
| Pubmed | 6.64e-04 | 281 | 49 | 4 | 24163370 | ||
| Pubmed | 6.67e-04 | 27 | 49 | 2 | 29374058 | ||
| Interaction | SP7 interactions | 7.19e-06 | 304 | 48 | 7 | int:SP7 | |
| Interaction | OR8B8 interactions | 3.32e-05 | 4 | 48 | 2 | int:OR8B8 | |
| Cytoband | 18q21.1 | 7.97e-04 | 38 | 50 | 2 | 18q21.1 | |
| GeneFamily | Collagens | 2.24e-08 | 46 | 34 | 5 | 490 | |
| Coexpression | NABA_COLLAGENS | 1.69e-08 | 43 | 49 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.90e-08 | 44 | 49 | 5 | M3005 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 3.39e-06 | 493 | 49 | 8 | M1951 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 3.99e-06 | 504 | 49 | 8 | MM830 | |
| Coexpression | NABA_CORE_MATRISOME | 1.09e-05 | 270 | 49 | 6 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.21e-05 | 275 | 49 | 6 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.78e-05 | 40 | 49 | 3 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL18A1 COL15A1 COL16A1 LOX ANXA11 CSPG4 COL25A1 SSPOP | 9.12e-05 | 1008 | 49 | 9 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 COL18A1 COL15A1 COL16A1 LOX ANXA11 CSPG4 COL25A1 SSPOP | 1.04e-04 | 1026 | 49 | 9 | M5889 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-08 | 198 | 50 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 171 | 50 | 5 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 178 | 50 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.87e-06 | 182 | 50 | 5 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 187 | 50 | 5 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-06 | 189 | 50 | 5 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 190 | 50 | 5 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-06 | 192 | 50 | 5 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 2.50e-06 | 193 | 50 | 5 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-06 | 193 | 50 | 5 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 193 | 50 | 5 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-06 | 193 | 50 | 5 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 193 | 50 | 5 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-06 | 195 | 50 | 5 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-06 | 195 | 50 | 5 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 197 | 50 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 197 | 50 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-06 | 199 | 50 | 5 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.90e-06 | 199 | 50 | 5 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 200 | 50 | 5 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.97e-06 | 200 | 50 | 5 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 135 | 50 | 4 | 5113bb1713f99d01103b9a99de5d80393081cf87 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 158 | 50 | 4 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 158 | 50 | 4 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 158 | 50 | 4 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 161 | 50 | 4 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.61e-05 | 166 | 50 | 4 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.78e-05 | 168 | 50 | 4 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.05e-05 | 171 | 50 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.14e-05 | 172 | 50 | 4 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.14e-05 | 172 | 50 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-05 | 174 | 50 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-05 | 175 | 50 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.43e-05 | 175 | 50 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-05 | 175 | 50 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 176 | 50 | 4 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 176 | 50 | 4 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-05 | 177 | 50 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 177 | 50 | 4 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-05 | 177 | 50 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-05 | 177 | 50 | 4 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 177 | 50 | 4 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.84e-05 | 179 | 50 | 4 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-05 | 179 | 50 | 4 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-05 | 179 | 50 | 4 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.94e-05 | 180 | 50 | 4 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 5.05e-05 | 181 | 50 | 4 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 181 | 50 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 181 | 50 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 182 | 50 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 182 | 50 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 183 | 50 | 4 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 183 | 50 | 4 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-05 | 184 | 50 | 4 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.50e-05 | 185 | 50 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-05 | 185 | 50 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-05 | 186 | 50 | 4 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.61e-05 | 186 | 50 | 4 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-05 | 186 | 50 | 4 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-05 | 186 | 50 | 4 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 187 | 50 | 4 | d52f7bc0afcdc366b20d199ab33c4ec60ed22a68 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 5.73e-05 | 187 | 50 | 4 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 187 | 50 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.73e-05 | 187 | 50 | 4 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-05 | 188 | 50 | 4 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.85e-05 | 188 | 50 | 4 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-05 | 188 | 50 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.97e-05 | 189 | 50 | 4 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 190 | 50 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 6.22e-05 | 191 | 50 | 4 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 50 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.48e-05 | 193 | 50 | 4 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 6.48e-05 | 193 | 50 | 4 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 193 | 50 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-05 | 193 | 50 | 4 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-05 | 193 | 50 | 4 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-05 | 193 | 50 | 4 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-05 | 193 | 50 | 4 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 6.48e-05 | 193 | 50 | 4 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.48e-05 | 193 | 50 | 4 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| Drug | foscarnet | 6.83e-09 | 190 | 49 | 8 | CID000003414 | |
| Drug | Madecassol | 4.80e-08 | 46 | 49 | 5 | CID000108062 | |
| Drug | BAPN | 4.38e-07 | 71 | 49 | 5 | CID000001647 | |
| Drug | GK-101 | 1.06e-06 | 36 | 49 | 4 | CID000161853 | |
| Drug | halofuginone lactate | 1.08e-06 | 85 | 49 | 5 | CID000062891 | |
| Drug | hydroxylysine | 3.70e-06 | 109 | 49 | 5 | CID000001029 | |
| Drug | d-indobufen | 4.05e-06 | 50 | 49 | 4 | CID000044562 | |
| Drug | ridogrel | 4.75e-06 | 52 | 49 | 4 | CID005362391 | |
| Drug | NSC49633 | 5.13e-06 | 53 | 49 | 4 | CID000023340 | |
| Drug | Selara | 7.23e-06 | 125 | 49 | 5 | CID000150310 | |
| Drug | DMSe | 9.43e-06 | 132 | 49 | 5 | CID000020796 | |
| Drug | AC1LAKND | 9.63e-06 | 62 | 49 | 4 | CID000470146 | |
| Drug | pirfenidone | 1.17e-05 | 138 | 49 | 5 | CID000040632 | |
| Drug | DL-penicillamine | 1.21e-05 | 139 | 49 | 5 | CID000004727 | |
| Drug | candesartan cilexetil | 1.49e-05 | 145 | 49 | 5 | CID000002540 | |
| Drug | malotilate | 1.65e-05 | 71 | 49 | 4 | CID000004006 | |
| Drug | AC1NMZ1B | 2.06e-05 | 75 | 49 | 4 | CID005034185 | |
| Drug | strontium ranelate | 2.28e-05 | 77 | 49 | 4 | CID006918182 | |
| Drug | khellin | 3.29e-05 | 171 | 49 | 5 | CID000003828 | |
| Drug | 4-hydroxyproline | 4.41e-05 | 91 | 49 | 4 | CID000000825 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 5.30e-05 | 189 | 49 | 5 | CID000001413 | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 5307_DN | |
| Drug | ticlopidine | 7.16e-05 | 103 | 49 | 4 | CID000005472 | |
| Drug | AC1L1C2F | 9.24e-05 | 110 | 49 | 4 | CID000001711 | |
| Drug | PPACK | 1.03e-04 | 113 | 49 | 4 | CID003036757 | |
| Drug | AC1L9732 | 1.06e-04 | 114 | 49 | 4 | CID000439300 | |
| Drug | Tranilast sodium | 1.10e-04 | 115 | 49 | 4 | CID000005527 | |
| Drug | 9-(5',5'-difluoro-5'-phosphonopentyl)guanine | 1.33e-04 | 46 | 49 | 3 | CID000448999 | |
| Drug | AC1Q6PCP | 1.34e-04 | 230 | 49 | 5 | CID000005267 | |
| Drug | losartan | 1.54e-04 | 378 | 49 | 6 | CID000003961 | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 4.20e-05 | 6 | 50 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | arteriosclerosis (implicated_via_orthology) | 5.88e-05 | 7 | 50 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 7.50e-05 | 48 | 50 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.01e-04 | 53 | 50 | 3 | C4707243 | |
| Disease | intraocular pressure measurement | 2.14e-04 | 509 | 50 | 6 | EFO_0004695 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.41e-04 | 71 | 50 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | macula measurement | 2.98e-04 | 189 | 50 | 4 | EFO_0008375 | |
| Disease | syndrome (implicated_via_orthology) | 4.23e-04 | 18 | 50 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | waist-hip ratio | 9.86e-04 | 1226 | 50 | 8 | EFO_0004343 | |
| Disease | hypertension (is_implicated_in) | 1.15e-03 | 121 | 50 | 3 | DOID:10763 (is_implicated_in) | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 1.52e-03 | 34 | 50 | 2 | DOID:9952 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQPAEGPQTAEGPQP | 121 | Q8N693 | |
| AAGSQPPAGPPAVQP | 2566 | Q96L91 | |
| PPGGFGQPPSAQQPV | 86 | P50995 | |
| LTAVPGQGPPPGGQP | 2286 | Q6UVK1 | |
| PGPPGQPGPAGISAV | 1296 | Q07092 | |
| PGGPQVPPALPQEGN | 1036 | Q6F5E8 | |
| AGVPPSAPLQGAVPP | 806 | O60641 | |
| IVECQPGPPGDQGPP | 431 | P02462 | |
| SGPDAPPNGPLQPGR | 36 | Q9ULW5 | |
| TPQTPGQPGAPATPG | 51 | P10589 | |
| PGIPPPGVMNQGVAP | 1531 | Q86U86 | |
| VGVLGPPGQQAPPPY | 1561 | Q86U86 | |
| AEEQGGPVPPPVAPG | 6 | Q16644 | |
| AVPAPTGAPPGGQPD | 596 | Q96AE4 | |
| PQPGPSTATGPQPAG | 3821 | Q9UPA5 | |
| RAPQAQPAPGPGPAG | 3856 | Q9UPA5 | |
| AGGPPGGPQVNPIPV | 176 | P13498 | |
| ESIRGQPGPPGPQGP | 1376 | P39060 | |
| TVTGPPGPPGPQGLQ | 446 | Q9BXS0 | |
| PEQGPPQLVQPDGPG | 166 | A0A1B0GTW7 | |
| QPQGTAQPPPGAPQG | 606 | Q71SY5 | |
| PVAPQVPSPGGAPGQ | 376 | Q9NZB2 | |
| GQPAEVDGNPPPAAP | 206 | A6NHQ4 | |
| GGPINPASLPPGDPQ | 36 | Q96IK1 | |
| LPPPGQKVGGSQPPF | 1736 | Q9BTC0 | |
| AGQQQPPREPPAAPG | 26 | P28300 | |
| QPRGNGANPPGAPPE | 1136 | O60336 | |
| GAAVALPGPPGPPGQ | 1111 | P39059 | |
| QVPPHQPGPPVVGAL | 681 | O95104 | |
| QPGPPVVGALQPPAF | 686 | O95104 | |
| PNTPGLLGTQPPAGP | 891 | Q9UPN6 | |
| EGPPLPAGVQVPAGP | 1076 | Q9BXA9 | |
| VAQPGPGPGEPPPAQ | 136 | Q05469 | |
| PPGAVAGPRPQQASP | 86 | Q96G74 | |
| EAAVGVPPPAQPAPG | 26 | Q8IV56 | |
| PAPVASPRPFQPGGG | 441 | Q9H987 | |
| EPQEGPPEQPTGPGQ | 96 | A6NDD5 | |
| PQPVAPALVPPAGGD | 136 | Q96N64 | |
| GSVQSPAPPQPGQPG | 281 | Q9Y2J0 | |
| SVAPGPFPPVQCGPG | 2381 | A2VEC9 | |
| LGPPAQVGAPAGPAP | 96 | Q9BXQ6 | |
| VGQPQPPPPPVGGAV | 271 | O75157 | |
| GPAGAGQPQSVPPPQ | 471 | O75157 | |
| PGGPHAVVPGVPNVP | 496 | O75157 | |
| PPQPPVAIAPGALNG | 411 | P78414 | |
| AQGGEPGQPAQPPPQ | 11 | P49354 | |
| GLQEPPPAPGPVAVA | 151 | P0DPQ3 | |
| GPSPPGPAQAPLQGD | 36 | Q9NUC0 | |
| QPAGAPQPGAVPPGV | 1026 | Q8TAQ2 | |
| LGPGAPAGAQPAQPP | 136 | O15105 | |
| PPAGGTAPPAVFGPQ | 2351 | Q9C0A1 | |
| AQAPAPAPGPAQGPL | 411 | Q9BW04 | |
| GGGAPAQPAAPPQPA | 66 | A1L020 | |
| DLPGPQAPPPSGLQG | 396 | Q9P227 | |
| GSAEAAPPPGQPPQV | 521 | Q2VWA4 | |
| QPPQVVANGPGSGPP | 531 | Q2VWA4 | |
| PGVPQGIPPQLTAAP | 636 | P49750 | |
| QQPAQPGPAASPAGP | 41 | Q14003 |